KYNB · Kyntra Bio, Inc. · Executive Compensation

$7.98 -0.07 (-0.81%) At close · Sep 10

Market Cap

$33.45M

4.05M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	Former Chief Executive Officer	$875,000	—	$4,490,726	$2,030,274	—	$41,427	$7,437,427
Thane Wettig	Chief Executive Officer	$573,334	—	$1,670,156	$1,028,878	$321,527	$46,934	$3,640,829
Mark Eisner	M.D., M.P.H. Former Chief Medical Officer	$650,000	—	$1,711,004	$780,329	—	$51,212	$3,192,545
Christine L. Chung	Senior Vice President, China Operations	$515,000	—	$1,432,544	$765,222	$225,776	$174,586	$3,113,128
Juan Graham	Chief Financial Officer	$505,000	—	$1,432,544	$765,222	$220,685	$166,803	$3,090,254

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	Former Chief Executive Officer	$850,000	—	$6,443,375	$2,779,684	$603,713	$64,302	$10,741,074
Mark Eisner	M.D., M.P.H. Former Chief Medical Officer	$630,000	—	$2,154,975	$932,780	$304,243	$58,710	$4,080,708
Christine L. Chung	Senior Vice President, China Operations	$505,000	—	$1,616,231	$699,585	$241,668	$528,070	$3,590,554
Thane Wettig	Chief Commercial Officer	$535,000	—	$1,616,231	$699,585	$253,483	$18,862	$3,123,161
Juan Graham	Chief Financial Officer	$480,000	$150,000	$808,116	$349,793	$226,848	$284,909	$2,299,666

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	Former Chief Executive Officer	$825,000	—	$4,346,820	$4,732,876	$422,297	$58,110	$10,385,103
Christine L. Chung	Senior Vice President, China Operations	$490,000	—	$1,688,225	$2,031,863	$180,707	$336,349	$4,727,144
Mark Eisner	M.D., M.P.H. Former Chief Medical Officer	$600,000	$1,000,000	$739,984	$1,157,212	$218,100	$52,310	$3,767,606
Pat Cotroneo	Chief Financial Officer	$515,000	—	$1,150,317	$1,845,874	$187,718	$57,824	$3,756,733
Elias Kouchakji	Senior Vice President, Clinical Development,	$213,750	—	$1,102,608	$1,766,492	—	$103,257	$3,186,107
Thane Wettig	Chief Commercial Officer	$510,000	—	$874,665	$1,590,542	$186,533	$12,855	$3,174,595
Juan Graham	Chief Financial Officer	$149,546	$150,000	$434,350	$1,446,166	$55,716	$22,179	$2,257,957

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Enrique Conterno	Chief Executive Officer	$790,909	$250,000	$2,601,000	$8,024,850	$554,400	$46,460	$12,267,619
Thane Wettig	Chief Commercial Officer	$263,258	$150,000	$1,262,400	$2,159,568	$122,158	$47,610	$4,004,994
Mark Eisner	M.D., M.P.H. Chief Medical Officer	$50,000	$500,000	$1,443,750	$1,919,616	—	$4,291	$3,917,657
K. Peony Yu	Former Chief Medical Officer	$612,000	—	$1,188,450	$1,201,950	$459,000	$51,364	$3,512,764
Pat Cotroneo	Chief Financial Officer	$508,000	—	$1,056,400	$1,061,723	$230,937	$58,959	$2,916,018
Elias Kouchakji	Senior Vice President, Clinical Development,	$570,000	—	$990,375	$1,001,625	$259,065	$64,215	$2,885,280
Christine L. Chung	Senior Vice President, China Operations	$480,000	—	$1,056,400	$1,061,723	$233,568	$47,916	$2,879,607
James A. Schoeneck	Interim Chief Executive Officer	$200,000	—	—	—	—	$517,343	$717,343

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas B. Neff	Chief Executive Officer	$687,115	—	$5,366,088	$5,333,469	—	$20,800	$11,407,472
K. Peony Yu	Former Chief Medical Officer	$590,000	—	$3,044,223	$1,886,018	$316,830	$19,380	$5,856,451
James A. Schoeneck	Interim Chief Executive Officer	$564,103	—	$2,347,008	$2,329,934	—	$6,920	$5,247,964
Elias Kouchakji	Senior Vice President, Clinical Development,	$550,000	—	$2,424,486	$1,697,417	$292,600	$20,586	$4,985,088
Drug Safety	and Pharmacovigilance	$550,000	—	$2,424,486	$1,697,417	$292,600	$20,586	$4,985,088
Christine L. Chung	Senior Vice President, China Operations	$440,000	—	$2,522,520	$1,366,680	$243,320	$17,766	$4,590,286
Pat Cotroneo	Chief Financial Officer	$490,000	—	$1,782,963	$1,769,851	$264,600	$18,972	$4,326,386
Thane Wettig	Chief Commercial Officer	—	—	—	—	—	—	—
Enrique Conterno	Chief Executive Officer	—	—	—	—	—	—	—
Mark Eisner	M.D., M.P.H. Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas B. Neff	Chief Executive Officer	$875,000	—	$3,762,500	$3,715,635	$847,875	$23,034	$9,224,044
K. Peony Yu	Former Chief Medical Officer	$564,000	—	$1,720,000	$1,857,818	$371,394	$19,152	$4,532,364
Pat Cotroneo	Chief Financial Officer	$471,000	—	$1,505,000	$1,283,583	$294,281	$17,662	$3,571,526
James A. Schoeneck	Interim Chief Executive Officer	—	—	—	—	—	—	—
Mark Eisner	M.D., M.P.H. Chief Medical Officer	—	—	—	—	—	—	—
Drug Safety	and Pharmacovigilance	—	—	—	—	—	—	—
Thane Wettig	Chief Commercial Officer	—	—	—	—	—	—	—
Enrique Conterno	Chief Executive Officer	—	—	—	—	—	—	—

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Thomas B. Neff	Chief Executive Officer	$840,000	—	$2,684,780	$2,850,751	$693,000	$20,160	$7,088,691
K. Peony Yu	Chief Medical Officer	$525,000	—	$1,045,870	$1,154,818	$393,750	$18,331	$3,137,769
Pat Cotroneo	Chief Financial Officer	$453,000	—	$971,169	$1,072,331	$249,150	$17,276	$2,762,926

Executive changes

Person	Role	Change	Effective	Filed
Aoife Brennan, M.B., B.Ch.	director	Resigned	2025-06-04	2025-06-09
Michael Kauffman, M.D., Ph.D.	Class III director	Appointed	2025-06-04	2025-06-09
David DeLucia	Chief Financial Officer	Appointed	2024-12-16	2024-12-16
Gerald Lema	director	Resigned	2024-09-30	2024-09-13
Benjamin Cravatt	director	Resigned	2024-09-30	2024-09-13
Suzanne Blaug	director	Resigned	2024-09-30	2024-09-13
Deyaa Adib, M.D.	Chief Medical Officer	Terminated	2024-11-01	2024-09-06
Juan Graham	Chief Financial Officer	Terminated	2024-12-15	2024-09-06

Key facts CIK 921299 CUSIP 31572Q881 13F (30d) 18 filings 18 filers Visit website Investor relations